ProPhase Labs’ Nebula Genomics Subsidiary Introduces Lowest Ever NGS Pricing of $249 for its Whole Genome Sequencing DNA Test
March 07, 2023 08:00 ET
|
ProPhase Labs, Inc.
Company Provides Update on Significant Progress at Nebula Genomics Subsidiary Garden City, NY, March 07, 2023 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase”), a growth oriented...
American Song Contest Star Cruz Rock to Go New Ways in Music Monetization
June 23, 2022 13:00 ET
|
Nebula Ltd.
LOS ANGELES, June 23, 2022 (GLOBE NEWSWIRE) -- Nebula Ltd. announces Cruz Rock to its expanding roster of talented musicians. The Latin Caribbean singer-songwriter will offer fractional ownership of...
ProPhase Labs Provides Business Update
October 13, 2021 08:30 ET
|
ProPhase Labs, Inc.
Garden City, NY, Oct. 13, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified biotech and genomics company, today announces that it expects its Q3 2021 COVID-19 testing...
NebulaECN Launches Instant Deep Liquidity and Radical Transparency for Crypto Market
March 15, 2021 10:11 ET
|
Nebula
TALLINN, Estonia, March 15, 2021 (GLOBE NEWSWIRE) -- Despite top crypto assets demonstrating impressive daily trading volumes, cryptocurrencies remain a thinly traded market, due to its...